企業プロフィール
Bolt Biotherapeutics 株価・ニュース・カタリスト
- ティッカー:
- BOLT
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
3.20 USD (-4.48%)
終値
最終更新: 2026年8月17日
9.82M USD
時価総額
株価変動の要因
As of Aug 17, 2026, BOLT closed down 4.48% at $3.20. No new same-company headline was identified in the current news window.
企業概要
Immune-Stimulating Antibody Conjugates
Bolt Biotherapeutics develops Boltbody immune-stimulating antibody conjugates that combine tumor targeting with activation of innate and adaptive immunity.
BDC-4182
BDC-4182 targets claudin 18.2 and is being evaluated in gastric, gastroesophageal junction, pancreatic, and other solid tumors.
Mechanistic Positioning
The program is designed to combine antibody-drug conjugate-like precision with durable immune activation associated with T-cell-engaging therapies.
今後のカタリスト
- Initial Phase 1/2 BDC-4182 clinical data in gastric and gastroesophageal cancers are expected in the third quarter of 2026.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。